These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8589346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation.
    Matsumura Y, Sakaida I, Uchida K, Kimura T, Ishihara T, Okita K.
    J Hepatol; 1997 Jul; 27(1):185-92. PubMed ID: 9252094
    [Abstract] [Full Text] [Related]

  • 4. Prevention of fibrosis reduces enzyme-altered lesions in the rat liver.
    Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K.
    Carcinogenesis; 1994 Oct; 15(10):2201-6. PubMed ID: 7955054
    [Abstract] [Full Text] [Related]

  • 5. Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis.
    Sakaida I, Uchida K, Hironaka K, Okita K.
    J Gastroenterol; 1999 Jun; 34(3):376-7. PubMed ID: 10433015
    [Abstract] [Full Text] [Related]

  • 6. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K.
    J Hepatol; 1998 Feb; 28(2):298-306. PubMed ID: 9514543
    [Abstract] [Full Text] [Related]

  • 7. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Okita K.
    J Hepatol; 2003 Jun; 38(6):762-9. PubMed ID: 12763369
    [Abstract] [Full Text] [Related]

  • 8. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K.
    Biochem Biophys Res Commun; 2004 Feb 27; 315(1):187-95. PubMed ID: 15013444
    [Abstract] [Full Text] [Related]

  • 9. Fibrosis accelerates the development of enzyme-altered lesions in the rat liver.
    Sakaida I, Hironaka K, Uchida K, Suzuki C, Kayano K, Okita K.
    Hepatology; 1998 Nov 27; 28(5):1247-52. PubMed ID: 9794908
    [Abstract] [Full Text] [Related]

  • 10. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo.
    Sakaida I, Uchida K, Matsumura Y, Okita K.
    J Hepatol; 1998 Mar 27; 28(3):471-9. PubMed ID: 9551686
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor.
    Bickel M, Baringhaus KH, Gerl M, Günzler V, Kanta J, Schmidts L, Stapf M, Tschank G, Weidmann K, Werner U.
    Hepatology; 1998 Aug 27; 28(2):404-11. PubMed ID: 9696004
    [Abstract] [Full Text] [Related]

  • 12. Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient L-amino acid-defined diet in rats.
    Sakaida I, Hironaka K, Uchida K, Okita K.
    Dig Dis Sci; 1999 Mar 27; 44(3):560-9. PubMed ID: 10080151
    [Abstract] [Full Text] [Related]

  • 13. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis.
    Hayasaka A, Koch J, Schuppan D, Maddrey WC, Hahn EG.
    J Hepatol; 1991 Nov 27; 13(3):328-38. PubMed ID: 1725528
    [Abstract] [Full Text] [Related]

  • 14. Prolyl hydroxylation regulates intracellular procollagen degradation in cultured rat cardiac fibroblasts.
    Eleftheriades EG, Ferguson AG, Spragia ML, Samarel AM.
    J Mol Cell Cardiol; 1995 Aug 27; 27(8):1459-73. PubMed ID: 8523410
    [Abstract] [Full Text] [Related]

  • 15. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver.
    Fujiwara K, Ogata I, Ohta Y, Hayashi S, Mishiro S, Takatsuki K, Sato Y, Yamada S, Hirata K, Oka H.
    Hepatology; 1988 Aug 27; 8(4):804-7. PubMed ID: 2839404
    [Abstract] [Full Text] [Related]

  • 16. [Experimental studies of the inhibition of fibrogenesis].
    Böker K, Schwarting G, Kaule G, Günzler V, Ohlendorf S, Schmidt E.
    Z Gastroenterol; 1992 Mar 27; 30 Suppl 1():43-5. PubMed ID: 1333142
    [Abstract] [Full Text] [Related]

  • 17. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, Tsunematsu S, Kumagai N, Ishii H, Saito H, Hibi T.
    J Gastroenterol Hepatol; 2007 Nov 27; 22(11):2022-33. PubMed ID: 17914985
    [Abstract] [Full Text] [Related]

  • 18. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Jin H, Sakaida I, Tsuchiya M, Okita K.
    Life Sci; 2005 Apr 29; 76(24):2805-16. PubMed ID: 15808881
    [Abstract] [Full Text] [Related]

  • 19. Changes in serum and hepatic levels of immunoreactive prolyl hydroxylase in two models of hepatic fibrosis in rats.
    Okuno M, Muto Y, Kato M, Moriwaki H, Noma A, Tagaya O, Tanabe Y.
    J Gastroenterol Hepatol; 1991 Apr 29; 6(3):271-7. PubMed ID: 1655096
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats.
    Denda A, Endoh T, Kitayama W, Tang Q, Noguchi O, Kobayashi Y, Akai H, Okajima E, Tsujiuchi T, Tsutsumi M, Nakae D, Konishi Y.
    Carcinogenesis; 1997 Oct 29; 18(10):1921-30. PubMed ID: 9364001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.